Antipsychotic medications appear to triple the risk of type 2 diabetes in children and teens, with most of the risk occurring in the first year of administration, according to a recent study. The study of more than 43,000 youths found the same threefold increase, no matter how the data were analyzed, William V. Bobo, M.D. and his colleagues reported in the online edition of JAMA Psychiatry.
The risk translated into an additional 15.8 cases of type 2 diabetes per person-year of antipsychotic treatment, according to the Vanderbilt University researchers. The study included 43,287 children and young adults ages six to 24 years. Of these, 28,858 had recently initiated antipsychotic therapy. The remainder served as matched controls and had recently started taking other psychotropic - but not antipsychotic - medications.
-Source: Journal of the American Medical Association's JAMA Psychiatry
Good Neighbor Pharmacy Health Connection, December 2013
Share with Friend
